SPECIFIC CLINICAL CONTRAINDICATIONS TO PET-CT INCLUDE: Pregnancy or suspected pregnancy
Clinical contraindications rendering the patient medically unfit to undergo the scan include:
Chest drains in situ, Influenza, Chickenpox (Varicella Zoster Virus), Measles (Rubella), Mumps, Clostridium Difficile (may only be scanned at static
centres), Whooping cough (Bordetella pertussis), Active Shingles (Herpes Zoster), Diphtheria (Corynebacterium diphtheriae)
Additional physical and technical contraindications to PET-CT include:
Inability to cooperate with the scan process - For instance, inability to lie relatively still for 1-2 hours and to lie supine for 30-60 minutes
Blood Glucose Level - If the patient’s blood glucose level is outside the ARSAC certificate holder’s agreed limits. In patients with diabetes this must be
adequately controlled prior to attendance for the PET-CT scan. Uncontrolled blood glucose levels may result in sub-optimal or undiagnostic image
quality and therefore in these circumstances the patient’s appointment may be cancelled and re-scheduled for an alternative date when
diabetic control has been established
Chemotherapy/Radiotherapy - If the patient’s appointment date is outside the ARSAC certificate holders agreed time limits
Patient body habitus above scanner dimensions - Scanner Bore Diameter 70cm (distance from scanner bed to roof of scanner approximately 50cm).
If it is uncertain if a patient’s body habitus will prevent us from proceeding with the scan the patient may be invited to attend the scanner prior to their
appointment date to undergo a trial run through the scanner gantry
CLINICAL INDICATION CODING (please tick one box from each table):
Lung Staging JA
Oesophagus Re-staging JB
Colorectal Recurrence JC
Lymphoma Residual Mass JD
Head & Neck
(includes H&N unknown primary) Please state: Follow Up (response to therapy) JE
Melanoma Characterisation JF
Unknown Primary
(excludes H&N unknown primary) Pre-resection Metastases JG
Upper GI
(includes Stomach, Small Bowel, Liver, Pancreas) Please state: Find Unknown Primary JH
Sarcoma Elevated Tumour Markers JI
Breast Paraneoplastic Syndrome JJ
Urological
(includes Renal, Adrenal, Bladder, Prostate, Testicle) Please state: Other Oncology JK
Gynaecological
(includes Ovary, Uterus, Cervix) Please state: Non-Oncology: Neurology JL
Brain & Spinal Cord Please state: Non-Oncology: Cardiac JM
Oncology: Other Please state: Non-Oncology: Other JN
Non-Oncology: Neurology
Non-Oncology: Cardiac
Non-Oncology: Other
(includes vasculitis, infection imaging) Please state:
Patient Name
Protocol required:
Date of Birth
Vertex to toes PET-CT
Base of skull to proximal third of femur PET-CT
Lung Apices to proximal third of femur PET-CT
Symphysis pubis to toes PET-CT
Vertex to proximal third of femur PET-CT
Vertex to Lung Apices PET-CT
Brain PET-CT
Other (please specify)
Prostate - Dynamic PET-CT
Other - Dynamic PET-CT
Clinical authorisation by ARSAC certificate holder or delegate:
Print Name:
Signature:
Date:
ARSAC PROCESS - ARSAC Certificate Holder or Delegate to complete
ARSAC Authorisation (please indicate) Pre-referral to PMC Under delegation
Tracer required:
FDG
Amyloid
NaF
FEC (choline)
Other (please state)
Can patient be scanned in Radiotherapy Planning Position? Yes No